Ronald Blair
Pediatrics · Dallas, TXNPI 1356396691
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $281, 2.8 times the $99 reported in 2019.
Across 68 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$242
- GSK$235
- Cranial Technologies, Inc$137
- Seqirus USA Inc$96
- Sanofi-aventis U.S. LLC$84
- Adlon Therapeutics L.p.$76
- plus $293 from 10 others
Across 298 payments — averaging $25,978 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$7.3M
- Pfizer$184K
- GSK$167K
- Sanofi Pasteur Inc.$123K
What the payments were for
- Food & beverage$1,164100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 13 | $242 |
| GSK | 15 | $235 |
| Cranial Technologies, Inc | 9 | $137 |
| Seqirus USA Inc | 6 | $96 |
| Sanofi-aventis U.S. LLC | 3 | $84 |
| Adlon Therapeutics L.p. | 4 | $76 |
| Tris Pharma Inc | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
| Merck | 3 | $46 |
| Sanofi Pasteur Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $27 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Hospira, Inc. | 1 | $12 |
How this compares
$1,164 in reported general payments places this provider in the 85th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Dallas
- Angela ScheuerleDallas$118K
- Ralph DeberardinisDallas$56K
- Anna SuessmanDallas$26K
- Marcial Oquendo RinconDallas$21K
- Albert KaramDallas$19K
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.